News Cipla Limited

Stocks

CIPLA

INE059A01026

Pharmaceuticals

Delayed NSE India S.E. 10:06:06 30/10/2026 +03			5-day change	1st Jan Change
1,373.80 ^INR	+1.16%		+2.65%	-9.12%

10-27	Cipla Limited, Q2 2027 Earnings Call, Oct 27, 2026
10-27	Cipla Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026	CI

All News

Mentions Relevance

10-27	Cipla Limited, Q2 2027 Earnings Call, Oct 27, 2026
10-27	Cipla Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026	CI
10-23	Cipla Unit's US Facility Gets Zero Observations in FDA Inspection	MT
10-06	Cipla Health Announces Appointment of Gaurav Kaul as Managing Director, Effective October 2026	CI
09-22	Cipla Limited and Cipla Usa Inc. Announces Management Changes, Effective October 1, 2026	CI
09-04	Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda in the US	AQ
09-04	Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda(R) (Pembrolizumab) in the US	AQ
08-25	Cipla's Pithampur, India Unit Gets 7 Observations From US FDA	MT
08-14	Cipla Announces Appointment of Runa Akhtar to Marketing Head, Cipla Urology	CI
07-28	Cipla Limited Receives U.S. Fda Approval for Generic Advair Diskus	CI
07-24	Jefferies Adjusts Cipla's Price Target to INR1,170 From INR1,120, Keeps at Underperform	MT
07-23	Cipla Limited, Q1 2027 Earnings Call, Jul 23, 2026
07-23	Cipla Redesignates Global CFO to New Internal Role; Names New CFO	MT
07-23	Cipla Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
07-23	Cipla Limited Announces Cessation of Sanjay Joseph as Senior Managerial Personnel, Effective July 24, 2026	CI
07-23	Cipla Limited Announces Global Chief Financial Officer Changes	CI
07-23	Cipla Limited Announces Executive Changes	CI
06-24	Avendus Spark Upgrades Cipla to Buy from Add; Price Target is INR1,710	MT
06-16	Cipla Limited Appoints Shivam Puri as Chief Executive Officer of Its One India Business, Effective July 1, 2026	CI
06-11	Cipla's Goa, India Facility Receives VAI Status from US FDA	MT
05-14	Cipla Limited announces Annual dividend, payable on July 25, 2026	CI
05-14	Elara Securities Downgrades Cipla to Reduce from Accumulate; Price Target is INR1,349	MT
05-14	Elara Securities Downgrades Cipla to Sell from Neutral; Price Target is INR1,180	MT
05-14	JM Financial Upgrades Cipla to Buy from Add; Price Target is INR1,546	MT
05-14	Emkay Global Upgrades Cipla to Add from Reduce; Price Target is INR1,450	MT